159 related articles for article (PubMed ID: 3329800)
1. Sabin and Salk poliovirus vaccine: vice versa.
Cohen HH
Acta Leiden; 1987; 56():65-83. PubMed ID: 3329800
[No Abstract] [Full Text] [Related]
2. Reassessment of the place of inactivated poliomyelitis vaccine in national immunization programmes.
Assaad F
Dev Biol Stand; 1981; 47():275-82. PubMed ID: 6262152
[No Abstract] [Full Text] [Related]
3. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
4. Salk vs. Sabin controversy.
Puliyel JM
Indian Pediatr; 1987 Aug; 24(8):690. PubMed ID: 3443513
[No Abstract] [Full Text] [Related]
5. Poliomyelitis--Israel.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Oct; 37(40):624-5. PubMed ID: 3139983
[No Abstract] [Full Text] [Related]
6. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
7. [Poliomyelitis: new revelations, renewed polemics and the Hungarian experiences].
Dömök I
Orv Hetil; 1983 Jun; 124(23):1355-67. PubMed ID: 6877813
[No Abstract] [Full Text] [Related]
8. [Poliomyelitis in the Netherlands].
Dekking F
Ned Tijdschr Geneeskd; 1978 Aug; 122(31):1142-3. PubMed ID: 673050
[No Abstract] [Full Text] [Related]
9. Polio endgame. Polio: The final assault?
Roberts L
Science; 2004 Mar; 303(5666):1960-8. PubMed ID: 15044779
[No Abstract] [Full Text] [Related]
10. [Behavior of morbidity in poliomyelitis in Salerno province in relation to vaccination campaigns using the Salk method and using the Sabin method].
Santoro M
Ann Sanita Pubblica; 1966; 27(2):375-83. PubMed ID: 5960605
[No Abstract] [Full Text] [Related]
11. [Polio disposed of, starting in and thanks to the Netherlands?].
Kapsenberg JG
Ned Tijdschr Geneeskd; 1983 Jul; 127(29):1303-5. PubMed ID: 6888596
[No Abstract] [Full Text] [Related]
12. Herd effect and virus eradication with use of killed poliovirus vaccine.
Salk D
Dev Biol Stand; 1981; 47():247-55. PubMed ID: 6262150
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology and control of poliomyelitis. II. Poliovirus vaccines].
Carrada-Bravo T
Bol Med Hosp Infant Mex; 1983 Nov; 40(11):604-12. PubMed ID: 6651947
[No Abstract] [Full Text] [Related]
14. Public health. Is polio eradication realistic?
Arita I; Nakane M; Fenner F
Science; 2006 May; 312(5775):852-4. PubMed ID: 16690846
[No Abstract] [Full Text] [Related]
15. Re: world wide experience with inactivated poliovirus vaccine.
Arya SC; Agarwal N
Vaccine; 2009 Jan; 27(1):1. PubMed ID: 18952133
[No Abstract] [Full Text] [Related]
16. Need for polio boosters after age two years.
Rennels MB
Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
[No Abstract] [Full Text] [Related]
17. Toward eradication of poliomyelitis by combined use of killed and live vaccines.
Melnick JL
Cardiovasc Res Cent Bull; 1982; 20(3):49-60. PubMed ID: 6805957
[No Abstract] [Full Text] [Related]
18. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
19. The excretion of type 1 poliovirus after challenge following primary immunization with quadruple, Salk and Sabin vaccines.
Mon Bull Minist Health Public Health Lab Serv; 1965 Nov; 24():365-9. PubMed ID: 4286153
[No Abstract] [Full Text] [Related]
20. Effect of Sabin poliovirus vaccine on incidence of poliomyelitis in Italy.
Giovanardi A
JAMA; 1969 Jul; 209(4):525-8. PubMed ID: 4307421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
